BIND Therapeutics: Q4 FY 2015 Results (BIND Therapeutics) - Mar 18, 2016 - Anticipated top-line data from P2 iNSITE 1 trial (NCT02283320) in squamous cell non-small cell lung cancer in April 2016; Anticipated top-line data from P2 iNSITE 2 trial (NCT02479178) in advanced cervical cancer and head and neck cancer in April 2016
Anticipated P2 data • Head and Neck Cancer • Non Small Cell Lung Cancer • Oncology • Uterine Cancer
|